TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF THE EUROPE MEDICAL AESTHETICS MARKET 16
1.4 LIMITATIONS 18
1.5 MARKETS COVERED 18
2 MARKET SEGMENTATION 21
2.1 MARKETS COVERED 21
2.2 GEOGRAPHICAL SCOPE 22
2.3 YEARS CONSIDERED FOR THE STUDY 23
2.4 CURRENCY AND PRICING 23
2.5 DBMR TRIPOD DATA VALIDATION MODEL 24
2.6 MULTIVARIATE MODELLING 27
2.7 PRODUCT TYPE LIFELINE CURVE 27
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.9 DBMR MARKET POSITION GRID 29
2.10 MARKET APPLICATION COVERAGE GRID 30
2.11 SECONDARY SOURCES 31
2.12 ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 35
4.1 PORTERS FIVE FORCES 36
4.2 PESTEL ANALYSIS 37
4.3 CUSTOMISED DATA: 38
4.3.1 INTRODUCTION 38
5 EUROPE MEDICAL AESTHETICS MARKET, REGULATIONS 45
6 MARKET OVERVIEW 49
6.1 DRIVERS 51
6.1.1 AGING POPULATION EUROPELY 51
6.1.2 TECHNOLOGICAL ADVANCEMENTS 51
6.1.3 KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE 52
6.2 RESTRAINTS 52
6.2.1 STRINGENT REGULATORY POLICIES 52
6.2.2 HIGH COST FOR THE TREATMENTS. 53
6.3 OPPORTUNITIES 53
6.3.1 IMMENT HEALTH REVOLUTION 53
6.3.2 GROWING MEDICAL TOURISM IN ASIA 54
6.4 CHALLENGE 55
6.4.1 INCREASING COMPETITORS 55
7 EUROPE MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE 56
7.1 OVERVIEW 57
7.2 AESTHETIC LASER DEVICES 60
7.2.1 ABLATIVE SKIN RESURFACING DEVICES 61
7.2.1.1 CO2 LASER 61
7.2.1.2 ERBIUM LASER 61
7.2.1.3 OTHERS 61
7.2.2 NON-ABLATIVE FRACTIONAL LASER RESURFACING DEVICES 61
7.2.2.1 RADIOFREQUENCY 62
7.2.2.2 INTENSE PULSED LIGHT 62
7.2.2.3 FRACTIONAL LASER 62
7.2.2.4 THE Q-SWITCHED ND:YAG LASER 62
7.2.2.5 OTHERS 62
7.3 ENERGY DEVICES 62
7.3.1 LASER SURGERY DEVICES 63
7.3.2 ELECTROCAUTERY DEVICES 63
7.3.3 ELECTROSURGERY DEVICES 63
7.3.4 CRYOSURGERY DEVICES 64
7.3.5 HARMONIC SCALPEL 64
7.3.6 MICROWAVE DEVICES 64
7.4 BODY CONTOURING DEVICES 64
7.4.1 LIPOSUCTION 65
7.4.2 NONSURGICAL SKIN TIGHTENING 65
7.4.3 CELLULITE TREATMENT 65
7.5 FACIAL AESTHETIC DEVICES 65
7.5.1 BOTOX INJECTION 66
7.5.2 DERMAL FILLERS 66
7.5.2.1 NATURAL DERMAL FILLERS 67
7.5.2.2 SYNTHETIC DERMAL FILLERS 67
7.5.3 COLLAGEN INJECTIONS 67
7.5.4 CHEMICAL PEEL 67
7.5.5 FACIAL TONING 67
7.5.6 FRAXEL 67
7.5.7 COSMETIC ACUPUNCTURE 67
7.5.8 ELECTROTHERAPY 67
7.5.9 MICRODERMABRASION 67
7.5.10 PERMANENT MAKEUP 68
7.6 AESTHETIC IMPLANTS 68
7.6.1 BREAST AUGMENTATION 69
7.6.1.1 SALINE IMPLANTS 69
7.6.1.2 SILICON IMPLANTS 69
7.6.2 BUTTOCK AUGMENTATION 69
7.6.3 AESTHETIC DENTAL IMPLANTS 70
7.6.3.1 DENTAL TITANIUM IMPLANTS 70
7.6.3.2 DENTAL ZERCONIUM IMPLANTS 70
7.6.4 FACIAL IMPLANTS 70
7.6.5 SOFT TISSUE IMPLANTS 70
7.6.6 TRANSDERMAL IMPLANT 70
7.6.7 OTHERS 70
7.7 SKIN AESTHETIC DEVICES 71
7.7.1 LASER SKIN RESURFACING DEVICES 72
7.7.2 NON SURGICAL SKIN TIGHTENING DEVICES 72
7.7.3 LIGHT THERAPY DEVICES 72
7.7.4 TATTOO REMOVAL DEVICES 72
7.7.5 MICRO-NEEDLING PRODUCTS 73
7.7.6 THREAD LIFT PRODUCTS 73
7.7.7 NAIL TREATMENT LASER DEVICES 73
7.7.8 OTHERS 73
8 EUROPE MEDICAL AESTHETICS MARKET, BY APPLICATION 74
8.1 OVERVIEW 75
8.2 ANTI-AGING AND WRINKLES 79
8.3 FACIAL AND SKIN REJUVENATION 79
8.4 BREAST ENHANCEMENT 80
8.5 BODY SHAPING AND CELLULITE 81
8.6 TATTOO REMOVAL 81
8.7 VASCULAR LESIONS 82
8.7.1 SEARS, PIGMENT LESIONS, RECONSTRUCTIVE 82
8.8 PSORIASIS AND VITILIGO 83
8.9 OTHERS 84
9 EUROPE MEDICAL AESTHETICS MARKET, BY END USER 85
9.1 OVERVIEW 86
9.2 COSMETIC CENTERS 89
9.3 DERMATOLOGY CLINICS 89
9.4 HOSPITALS 90
9.5 MEDICAL SPAS AND BEAUTY CENTERS 90
10 EUROPE MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL 91
10.1 OVERVIEW 92
10.2 DIRECT TENDER 94
10.3 RETAIL 95
11 EUROPE MEDICAL AESTHETIC DEVICES MARKET, BY REGION 96
11.1 EUROPE 97
11.1.1 GERMANY 101
11.1.2 U.K. 101
11.1.3 FRANCE 101
11.1.4 ITALY 101
11.1.5 SPAIN 101
11.1.6 RUSSIA 101
11.1.7 NETHERLANDS 101
11.1.8 SWITZERLAND 101
11.1.9 BELGIUM 101
11.1.10 TURKEY 101
11.1.11 REST OF EUROPE 101
12 EUROPE MEDICAL AESTHETICS MARKET: COMPANY LANDSCAPE 102
12.1 COMPANY SHARE ANALYSIS: EUROPE 102
13 COMPANY PROFILE 103
13.1 ALLERGAN 103
13.1.1 COMPANY SNAPSHOT 103
13.1.2 SWOT ANALYSIS 104
13.1.3 REVENUE ANALYSIS 105
13.1.4 COMPANY SHARE ANALYSIS 105
13.1.5 PRODUCT PORTFOLIO 106
13.1.6 RECENT DEVELOPMENTS 106
13.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS 107
13.2 BAUSCH HEALTH COMPANIES INC. 108
13.2.1 COMPANY SNAPSHOT 108
13.2.2 SWOT ANALYSIS 109
13.2.3 REVENUE ANALYSIS 110
13.2.4 PRODUCT PORTFOLIO 110
13.2.5 RECENT DEVELOPMENTS 111
13.2.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 111
13.3 LUMENIS 112
13.3.1 COMPANY SNAPSHOT 112
13.3.2 SWOT ANALYSIS 113
13.3.3 COMPANY SHARE ANALYSIS 114
13.3.4 PRODUCT PORTFOLIO 114
13.3.5 RECENT DEVELOPMENTS 115
13.3.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 115
13.4 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD. 116
13.4.1 COMPANY SNAPSHOT 116
13.4.2 SWOT ANALYSIS 117
13.4.3 REVENUE ANALYSIS 118
13.4.4 PRODUCT PORTFOLIO 118
13.4.5 RECENT DEVELOPMENTS 119
13.4.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 119
13.5 CYNOSURE 120
13.5.1 COMPANY SNAPSHOT 120
13.5.2 SWOT ANALYSIS 121
13.5.3 COMPANY SHARE ANALYSIS 122
13.5.4 PRODUCT PORTFOLIO 122
13.5.5 RECENT DEVELOPMENTS 124
13.5.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 124
13.6 AEROLASE CORP. 125
13.6.1 COMPANY SNAPSHOT 125
13.6.2 PRODUCT PORTFOLIO 125
13.6.3 RECENT DEVELOPMENTS 125
13.7 A.R.C. LASER GMBH 126
13.7.1 COMPANY SNAPSHOT 126
13.7.2 PRODUCT PORTFOLIO 126
13.7.3 RECENT DEVELOPMENT 127
13.8 ASCLEPION LASER TECHNOLOGIES GMBH 128
13.8.1 COMPANY SNAPSHOT 128
13.8.2 PRODUCT PORTFOLIO 128
13.8.3 RECENT DEVELOPMENT 129
13.9 BTL 130
13.9.1 COMPANY SNAPSHOT 130
13.9.2 PRODUCT PORTFOLIO 130
13.9.3 RECENT DEVELOPMENTS 131
13.10 CUTERA 132
13.10.1 COMPANY SNAPSHOT 132
13.10.2 REVENUE ANALYSIS 132
13.10.3 COMPANY SHARE ANALYSIS 133
13.10.4 PRODUCT PORTFOLIO 133
13.10.5 RECENT DEVELOPMENTS 134
13.11 ECLIPSE 135
13.11.1 COMPANY SNAPSHOT 135
13.11.2 PRODUCT PORTFOLIO 135
13.11.3 RECENT DEVELOPMENTS 135
13.12 LUTRONIC 136
13.12.1 COMPANY SNAPSHOT 136
13.12.2 PRODUCT PORTFOLIO 136
13.12.3 RECENT DEVELOPMENTS 137
13.13 MENTOR WORLDWIDE LLC 138
13.13.1 COMPANY SNAPSHOT 138
13.13.2 REVENUE ANALYSIS 138
13.13.3 COMPANY SHARE ANALYSIS 139
13.13.4 PRODUCT PORTFOLIO 139
13.13.5 RECENT DEVELOPMENT 140
13.14 MERZ PHARMA 141
13.14.1 COMPANY SNAPSHOT 141
13.14.2 PRODUCT PORTFOLIO 141
13.14.3 RECENT DEVELOPMENTS 142
13.15 QUANTA SYSTEM 143
13.15.1 COMPANY SNAPSHOT 143
13.15.2 PRODUCT PORTFOLIO 143
13.15.3 RECENT DEVELOPMENTS 144
13.16 SCITON INC. 145
13.16.1 COMPANY SNAPSHOT 145
13.16.2 PRODUCT PORTFOLIO 145
13.16.3 RECENT DEVELOPMENTS 146
13.17 SHARPLIGHT TECHNOLOGIES INC 147
13.17.1 COMPANY SNAPSHOT 147
13.17.2 PRODUCT PORTFOLIO 147
13.17.3 RECENT DEVELOPMENT 148
13.18 SYNERON MEDICAL LTD. 149
13.18.1 COMPANY SNAPSHOT 149
13.18.2 PRODUCT PORTFOLIO 149
13.18.3 RECENT DEVELOPMENTS 151
13.19 VENUS CONCEPT 152
13.19.1 COMPANY SNAPSHOT 152
13.19.2 PRODUCT PORTFOLIO 152
13.19.3 RECENT DEVELOPMENTS 154
14 QUESTIONNAIRE 155
15 RELATED REPORTS 161

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.